The Otrexup web-site announces availability to patients in January of 2014 -
Does this indicate an early launch - Maybe, but it sure seems like it won't be
The Antares Investor presentation states the two of the 12- 18 month
goals are a Global Licensing agreement for Otrexup and one for Psoriasis;
management seemed so confident of approval that I am guessing they have
their pins aligned well in advance and these agreements are in the works
and will be sooner rather than later.
We are expecting, maybe any time now, Two TEVA approvals and the Epi-
Pen product is thought to be an extremely valuable asset and revenue producer.
Two analysts raised their price targets immediately after approval.
We are expecting disclosure of the Pfizer product (we already know what
it is, but it will be nice to have it "official").
We expect clinical data from QST and more information about QSM. These
should be larger opportunities than Otrexup and I expect excellent results.
tappy has been B.S.in everybody for TWO plus years now with the same old cotton-candy slock---if this never ending mindless pumping supports the get rich fantasy ,fine, iwas tired of it years ago----otrexup will not be sold till early jan.---must wait at least one quarter for hoping for robust sales to boost pps, no guarantee there--QST not marketed till --16- so more of the same ' moving of goal posts, by tappy eventually pps will increase, but somewhere in the distant future?!?!
Tappy is not pumping a stock. He simply believes in this company and owns shares to back up his words. Furthermore, the company continues to deliver on its promises and has returned 50% annualized returns for investors over the last 5 years. What am I missing??
Well, some people are pessimists and some are optimists. Pessimists always seems to talk themselves out of a good deal. Their negative outlooks often end in self fulfilling feeling prophecies, meaning they create their failures in life. Most of what is discussed here is known as ex-ante. This means they are planned events. Now, if planned events vary much from actual events (ex-post) then pessimists may have an argument here. So far, planned events have been right on target, so all they have now are weak arguments about price. Some will talk themselves out of $5, $6, $7, etc...Do they ever learn.